[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @adamfeuerstein Adam Feuerstein ✡️ Adam Feuerstein ✡️ posts on X about $srpt, sarepta therapeutics, brazil, $alks the most. They currently have XXXXXXX followers and XXX posts still getting attention that total XXXXXX engagements in the last XX hours. ### Engagements: XXXXXX [#](/creator/twitter::102094857/interactions)  - X Week XXXXXXX +245% - X Month XXXXXXXXX -XX% - X Months XXXXXXXXX +64% - X Year XXXXXXXXX +37% ### Mentions: XX [#](/creator/twitter::102094857/posts_active)  - X Month XXX -XX% - X Months XXX -XXXX% - X Year XXX +138% ### Followers: XXXXXXX [#](/creator/twitter::102094857/followers)  - X Week XXXXXXX +0.40% - X Month XXXXXXX +0.96% - X Months XXXXXXX +2.50% - X Year XXXXXXX +3.70% ### CreatorRank: XXXXXXX [#](/creator/twitter::102094857/influencer_rank)  ### Social Influence [#](/creator/twitter::102094857/influence) --- **Social category influence** [stocks](/list/stocks) #3332 [finance](/list/finance) XXXX% [countries](/list/countries) XXXX% **Social topic influence** [$srpt](/topic/$srpt) #1, [sarepta therapeutics](/topic/sarepta-therapeutics) #4, [brazil](/topic/brazil) #302, [$alks](/topic/$alks) #2, [reversal](/topic/reversal) 1.71%, [$cogt](/topic/$cogt) 1.71%, [$bpmc](/topic/$bpmc) 1.71%, [$abvx](/topic/$abvx) 1.71%, [debt](/topic/debt) 1.71%, [$tak](/topic/$tak) XXXX% **Top accounts mentioned or mentioned by** [@jasonmmast](/creator/undefined) [@mbrushstocks](/creator/undefined) [@biotechch](/creator/undefined) [@yachmod](/creator/undefined) [@matthewherper](/creator/undefined) [@elaineywchen](/creator/undefined) [@drewqjoseph](/creator/undefined) [@financebully](/creator/undefined) [@sanctuarybio](/creator/undefined) [@jacobplieth](/creator/undefined) [@bambossie81](/creator/undefined) [@bimiki](/creator/undefined) [@alderlaneeggs](/creator/undefined) [@optionsplayer18](/creator/undefined) [@biohazard3737](/creator/undefined) [@cgrantwsj](/creator/undefined) [@srg444](/creator/undefined) [@kimchi_trades](/creator/undefined) [@rickberke](/creator/undefined) [@commonsenseplay](/creator/undefined) **Top assets mentioned** [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Alkermes Inc. plc (ALKS)](/topic/$alks) [Blueprint Medicines Corporation (BPMC)](/topic/$bpmc) [Intellia Therapeutics, Inc (NTLA)](/topic/$ntla) [Novartis AG (NVS)](/topic/$nvs) [Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn) [Pfizer, Inc. (PFE)](/topic/$pfe) [Synthetify (SNY)](/topic/$sny) [Sanofi (SNY)](/topic/sanofi) [Summit Therapeutics Inc. Common Stock (SMMT)](/topic/$smmt) [ATAI Life Sciences (ATAI)](/topic/$atai) [UnitedHealth Group (UNH)](/topic/$unh) ### Top Social Posts [#](/creator/twitter::102094857/posts) --- Top posts by engagements in the last XX hours "UPDATED:. Sarepta Therapeutics $SRPT crisis is huge blow to Duchenne families company Company has refused FDA request that it pull gene therapy from the market following patient deaths"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1946358008436461589) 2025-07-18 23:54:45 UTC 119.4K followers, 48.5K engagements "The podcast interview I mentioned earlier: A mothers perspective on Sareptas $SRPT gene therapy halt via @statnews"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1948417194670326080) 2025-07-24 16:17:13 UTC 119.4K followers, 18K engagements "$SRPT More confirmation here from @Jared_Whitlock of what we heard. The patient death occurred one month ago. Let that sink in when you think back to yesterday"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1946020282906321311) 2025-07-18 01:32:45 UTC 119.4K followers, 49.6K engagements "$SRPT The death referred to in the FDA statement may be the boy from Brazil who was disclosed earlier today by Brazilian authorities. Details in that announcement were scant but the timing of that death and age described in the FDA statement fit what STAT had learned about that case. Will let you know if I confirm"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1948864978733105494) 2025-07-25 21:56:33 UTC 119.4K followers, 14.7K engagements "Drugmakers are racing to help patients stay awake and could also make billions A great read from my colleague @elaineywchen reporting on the development of orexin inhibitors $ALKS $CNTA $TAK Link below"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1947632592309637171) 2025-07-22 12:19:29 UTC 119.4K followers, 9224 engagements "NEW: Sarepta Therapeutics $SRPT crisis is huge blow to Duchenne families company Our attempt to put the past 20-ish insane hours into perspective. via @Jasonmmast and me"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1946306897440559372) 2025-07-18 20:31:39 UTC 119.4K followers, 13.8K engagements "Why did $SRPT reverse course Sarepta says this "proactive" step will give it time to confer with FDA and remove Elevidys from its regulatory limbo (meaning hopefully keeping the drug on the market for ambulatory patients.) But Sarepta was also forced into this reversal bc hospitals were pausing use of Elevidys out of caution and safety/liability concerns STAT learned"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1947454466707324993) 2025-07-22 00:31:41 UTC 119.3K followers, 8985 engagements "$SRPT FDA will request Sarepta Therapeutics voluntarily stop all shipments of Elevidys - Reuters citing a source familiar with the matter Stock halted"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1946254296137228503) 2025-07-18 17:02:38 UTC 119.3K followers, 32.8K engagements "$NTLA clinical update: 8K This new Liver tox. In addition enrollment in our global Phase X MAGNITUDE study of nex-z for ATTR-CM is progressing according to our expectations. Currently we have enrolled approximately XXX patients in the MAGNITUDE study out of an expected total enrollment of approximately XXX patients and anticipate enrollment completion by early 2027. Over two hundred patients have been dosed with nex-z in the MAGNITUDE study. To date reported adverse events have been similar in nature to the reported adverse events in the Phase X study of nex-z for ATTR amyloidosis and have"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1927829257234870741) 2025-05-28 20:48:06 UTC 119.4K followers, 40.4K engagements "Why Sarepta may not survive its current gene therapy crisis. Plus: Who gets to decide the CEOs fate"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1948361333096751402) 2025-07-24 12:35:15 UTC 119.4K followers, 6825 engagements "Cogent Biosciences $COGT drug improves symptoms of chronic immune disorder study results show A comparison of the therapy to a rival treatment from Blueprint Medicines $BPMC remains muddled"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1942236971587223654) 2025-07-07 14:59:13 UTC 119.3K followers, 10.4K engagements "Small biotech Abivax $ABVX scores major win with ulcerative colitis trials Stock trading +400% to $XX this morning. Incredible via @DrewQJoseph"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1947950831896076362) 2025-07-23 09:24:04 UTC 119.4K followers, 12.9K engagements "George Tidmarsh named new CDER chief per Bloomberg"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1947245710530732146) 2025-07-21 10:42:10 UTC 119.4K followers, 12.5K engagements "Just in the past week Takeda announced that two late-stage trials succeeded and Alkermes disclosed its mid-stage study was positive saying that its therapy helped patients reach normal levels of wakefulness. Along with Centessa Pharmaceuticals the drugmakers are also testing orexin candidates in narcolepsy type X and idiopathic hypersomnia other sleep conditions that the drugs have shown early potential to treat. In these three rare sleep disorders alone analysts project a greater than $X billion market with potential to grow even bigger as more patients seek diagnoses and treatment"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1947632595648360598) 2025-07-22 12:19:30 UTC 119.4K followers, 5107 engagements "$SRPT Fully updated story w/ Brazil Japan suspensions Elevidys patient death in Brazil said to be due to influenza Europe moves to reject embattled Duchenne muscular dystrophy gene therapy via @DrewQJoseph"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1948729221993435506) 2025-07-25 12:57:06 UTC 119.4K followers, 9865 engagements "Regenerons Yancopoulos is still bitter over Praluent sales. Can Novartis do better $REGN $NVS $MDCO #JPM20"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1217481878216667136) 2020-01-15 16:21:14 UTC 119.3K followers, XX engagements "$SRPT Its always my fault. Or the medias fault. 🙄 Well folks I didnt cause Sareptas clinical trials to fail. I didnt decide to approve Elevidys for a broad swath of DMD patients. I dont treat patients nor influence whether they benefit or not. Im not responsible for liver failure hospitalizations or deaths. I didnt set Sareptas material disclosure policy. The FDA didnt ask for my advice on whether to ask Sarepta to halt shipments and Sarepta didnt consult with me when it refused. I dont work for Sarepta. I dont work for the FDA. I have no financial ties to Sarepta. No financial disclosures"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1946989884218179682) 2025-07-20 17:45:36 UTC 119.4K followers, 61.1K engagements "$SRPT Bloomberg story just published confirmed our reporting from yesterday"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1948131463850807473) 2025-07-23 21:21:50 UTC 119.4K followers, 20.2K engagements "$SRPT FDA Investigating Death of 8-Year-Old Boy Who Received Elevidys So sad"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1948860731610325394) 2025-07-25 21:39:41 UTC 119.4K followers, 33.8K engagements "$SRPT just announced pause to all Elevidys shipments in the US"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1947442773977927816) 2025-07-21 23:45:13 UTC 119.4K followers, 46.7K engagements "$SRPT CEO Doug Ingram concludes today's conference call by saying "We are a very transparent organization.""  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1946227685128089613) 2025-07-18 15:16:53 UTC 119.3K followers, 25.8K engagements "BREAKING: In surprise reversal Sarepta $SRPT says it will pause shipments of Duchenne gene therapy via @Jasonmmast and me"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1947453283095703860) 2025-07-22 00:26:59 UTC 119.4K followers, 24.6K engagements "EXCLUSIVE: Sarepta Therapeutics $SRPT Duchenne therapy faces arduous path back to market senior FDA official says via @Jasonmmast and me"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1947727145511620921) 2025-07-22 18:35:13 UTC 119.4K followers, 49.1K engagements "This week's Biotech Scorecard digs deeper into the Sarepta $SRPT #Duchenne gene therapy debacle. X. Sarepta may not survive. If Elevidys cannot return to the market (and STAT's reporting this week suggests it will not) the company is facing a severe cash flow and debt crisis. I dig deeper into the numbers. X. Putting business and stock prices aside this week has been wrenching for Duchenne families. On this week's Readout LOUD podcast we spoke with the mother of a boy who was treated with Elevidys. She wants Sarepta and the FDA to reach an agreement that returns Elevidys to the market. Listen"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1948361331830067249) 2025-07-24 12:35:14 UTC 119.4K followers, 24.8K engagements "@Sanctuary_Bio @JacobPlieth @ApexOnco $COGT CEO leans too heavily into the $BPMC avi hate. Let the data speak for itself without the passive-aggressive insults. It's counterproductive"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1942296407135653987) 2025-07-07 18:55:24 UTC 119.3K followers, 2241 engagements "$PFE bought a PD1xVEGF antibody from Chinas 3SBio. $1.25B upfront"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1924619787079921967) 2025-05-20 00:14:49 UTC 119.4K followers, 42.1K engagements "$SRPT With Elevidys paused risk to balance sheet and solvency is an issue again. Obviously will depend on how long Elevidys remains off the market and whether Sarepta can restructure debt if necessary"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1947461414823841928) 2025-07-22 00:59:18 UTC 119.4K followers, 24K engagements "More $SRPT news: FDA Requests Sarepta Therapeutics Suspend Distribution of Elevidys and Places Clinical Trials on Hold for Multiple Gene Therapy Products Following X Deaths Sarepta refused"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1946346984152973317) 2025-07-18 23:10:57 UTC 119.3K followers, 40.4K engagements "What the f--k is this person talking about"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1946992738789884367) 2025-07-20 17:56:56 UTC 119.3K followers, 28.8K engagements "Sanofi $SNY to buy vaccine biotech Vicebio for $1.15B upfront via @DrewQJoseph"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1947599400416498024) 2025-07-22 10:07:36 UTC 119.4K followers, 18.8K engagements "Akeso and $SMMT Ivonescimab in Combination with Chemotherapy Demonstrates Statistically Significant and Strongly Positive Results in First-Line Treatment of Squamous Non-Small Cell Lung Cancer (sq-NSCLC) vs. Tislelizumab in Combination with Chemotherapy"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1914991167441142027) 2025-04-23 10:34:07 UTC 119.3K followers, 15.7K engagements "Alkermes $ALKS drug helped narcolepsy patients stay awake in Phase X trial More orexin results but no numbers for now. via @elaineywchen"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1947237601028571284) 2025-07-21 10:09:56 UTC 119.3K followers, 9421 engagements "Psychedelic therapy from $ATAI and Beckley Psytech shows promise in mid-stage study in treatment-resistant depression via @megkesh"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1939989193985335739) 2025-07-01 10:07:21 UTC 119.4K followers, 15.5K engagements "Now official and then some. Sarepta Therapeutics $SRPT lays off one-third of workforce in drastic cost-cutting move w/ @Jasonmmast"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1945579122706599958) 2025-07-16 20:19:44 UTC 119.3K followers, 11K engagements "CONFIRMED: FDA to request Sarepta Therapeutics $SRPT halt shipments of Duchenne gene therapy"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1946260914505646144) 2025-07-18 17:28:56 UTC 119.4K followers, 20.4K engagements "Sarepta Therapeutics $SRPT the maker of a gene therapy for Duchenne muscular dystrophy that is being temporarily shelved because of safety concerns faces an arduous and treacherous path to try to get it back onto the market a senior official at the Food and Drug Administration told STAT suggesting the treatments license could be revoked"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1947727324528476319) 2025-07-22 18:35:55 UTC 119.4K followers, 16.8K engagements "I'm just seeing this now but Joe Schwartz at Leerink is doing hero's work today on $SRPT"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1946367772339913053) 2025-07-19 00:33:33 UTC 119.4K followers, 35.7K engagements "Needless to say the last XX hours have been stunning for $SRPT. Shocking. Frustrating. Aggravating. Maddening. The fallout will impact gene therapy and all of biotech"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1946263332555473165) 2025-07-18 17:38:32 UTC 119.3K followers, 78.4K engagements "FDA rejecting $CAPR deramiocel follows STAT reporting last month. The ouster of the FDAs chief regulator of cell and gene therapies earlier this week came immediately after a disagreement with her boss over the review of a cell therapy for Duchenne muscular dystrophy STAT has learned. The regulator Nicole Verdun had scheduled an advisory committee meeting to review the therapy developed by Capricor Therapeutics. But Vinay Prasad director of the FDAs Center for Biologics Evaluation and Research was skeptical of the treatment and decided unilaterally to cancel the meeting according to a person"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1943623141663621164) 2025-07-11 10:47:22 UTC 119.3K followers, 42K engagements "BioX in total might be dimmed these days but there are some individuals on this platform sharing fantastic and profitable investment ideas. BIG hat tip to @A_May_MD @Biohazard3737 @seedy19tron for an amazing call on $ABVX and anyone else who contributed to this. Wow"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1947951808753602905) 2025-07-23 09:27:57 UTC 119.4K followers, 8283 engagements "The crisis over Sareptas $SRPT Duchenne therapy is a mess. But the lesson is clear via @matthewherper"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1947366347723116596) 2025-07-21 18:41:32 UTC 119.4K followers, 9946 engagements "UnitedHealth $UNH confirms DOJ investigations into Medicare practices says its cooperating via @TaraBannow"  [@adamfeuerstein](/creator/x/adamfeuerstein) on [X](/post/tweet/1948386169655275544) 2025-07-24 14:13:56 UTC 119.4K followers, 7178 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@adamfeuerstein Adam Feuerstein ✡️
Adam Feuerstein ✡️ posts on X about $srpt, sarepta therapeutics, brazil, $alks the most. They currently have XXXXXXX followers and XXX posts still getting attention that total XXXXXX engagements in the last XX hours.
Engagements: XXXXXX #
- X Week XXXXXXX +245%
- X Month XXXXXXXXX -XX%
- X Months XXXXXXXXX +64%
- X Year XXXXXXXXX +37%
Mentions: XX #
- X Month XXX -XX%
- X Months XXX -XXXX%
- X Year XXX +138%
Followers: XXXXXXX #
- X Week XXXXXXX +0.40%
- X Month XXXXXXX +0.96%
- X Months XXXXXXX +2.50%
- X Year XXXXXXX +3.70%
CreatorRank: XXXXXXX #
Social Influence #
Social category influence stocks #3332 finance XXXX% countries XXXX%
Social topic influence $srpt #1, sarepta therapeutics #4, brazil #302, $alks #2, reversal 1.71%, $cogt 1.71%, $bpmc 1.71%, $abvx 1.71%, debt 1.71%, $tak XXXX%
Top accounts mentioned or mentioned by @jasonmmast @mbrushstocks @biotechch @yachmod @matthewherper @elaineywchen @drewqjoseph @financebully @sanctuarybio @jacobplieth @bambossie81 @bimiki @alderlaneeggs @optionsplayer18 @biohazard3737 @cgrantwsj @srg444 @kimchi_trades @rickberke @commonsenseplay
Top assets mentioned Sarepta Therapeutics, Inc. (SRPT) Alkermes Inc. plc (ALKS) Blueprint Medicines Corporation (BPMC) Intellia Therapeutics, Inc (NTLA) Novartis AG (NVS) Regeneron Pharmaceuticals Inc (REGN) Pfizer, Inc. (PFE) Synthetify (SNY) Sanofi (SNY) Summit Therapeutics Inc. Common Stock (SMMT) ATAI Life Sciences (ATAI) UnitedHealth Group (UNH)
Top Social Posts #
Top posts by engagements in the last XX hours
"UPDATED:. Sarepta Therapeutics $SRPT crisis is huge blow to Duchenne families company Company has refused FDA request that it pull gene therapy from the market following patient deaths"
@adamfeuerstein on X 2025-07-18 23:54:45 UTC 119.4K followers, 48.5K engagements
"The podcast interview I mentioned earlier: A mothers perspective on Sareptas $SRPT gene therapy halt via @statnews" @adamfeuerstein on X 2025-07-24 16:17:13 UTC 119.4K followers, 18K engagements
"$SRPT More confirmation here from @Jared_Whitlock of what we heard. The patient death occurred one month ago. Let that sink in when you think back to yesterday" @adamfeuerstein on X 2025-07-18 01:32:45 UTC 119.4K followers, 49.6K engagements
"$SRPT The death referred to in the FDA statement may be the boy from Brazil who was disclosed earlier today by Brazilian authorities. Details in that announcement were scant but the timing of that death and age described in the FDA statement fit what STAT had learned about that case. Will let you know if I confirm" @adamfeuerstein on X 2025-07-25 21:56:33 UTC 119.4K followers, 14.7K engagements
"Drugmakers are racing to help patients stay awake and could also make billions A great read from my colleague @elaineywchen reporting on the development of orexin inhibitors $ALKS $CNTA $TAK Link below" @adamfeuerstein on X 2025-07-22 12:19:29 UTC 119.4K followers, 9224 engagements
"NEW: Sarepta Therapeutics $SRPT crisis is huge blow to Duchenne families company Our attempt to put the past 20-ish insane hours into perspective. via @Jasonmmast and me" @adamfeuerstein on X 2025-07-18 20:31:39 UTC 119.4K followers, 13.8K engagements
"Why did $SRPT reverse course Sarepta says this "proactive" step will give it time to confer with FDA and remove Elevidys from its regulatory limbo (meaning hopefully keeping the drug on the market for ambulatory patients.) But Sarepta was also forced into this reversal bc hospitals were pausing use of Elevidys out of caution and safety/liability concerns STAT learned" @adamfeuerstein on X 2025-07-22 00:31:41 UTC 119.3K followers, 8985 engagements
"$SRPT FDA will request Sarepta Therapeutics voluntarily stop all shipments of Elevidys - Reuters citing a source familiar with the matter Stock halted" @adamfeuerstein on X 2025-07-18 17:02:38 UTC 119.3K followers, 32.8K engagements
"$NTLA clinical update: 8K This new Liver tox. In addition enrollment in our global Phase X MAGNITUDE study of nex-z for ATTR-CM is progressing according to our expectations. Currently we have enrolled approximately XXX patients in the MAGNITUDE study out of an expected total enrollment of approximately XXX patients and anticipate enrollment completion by early 2027. Over two hundred patients have been dosed with nex-z in the MAGNITUDE study. To date reported adverse events have been similar in nature to the reported adverse events in the Phase X study of nex-z for ATTR amyloidosis and have" @adamfeuerstein on X 2025-05-28 20:48:06 UTC 119.4K followers, 40.4K engagements
"Why Sarepta may not survive its current gene therapy crisis. Plus: Who gets to decide the CEOs fate" @adamfeuerstein on X 2025-07-24 12:35:15 UTC 119.4K followers, 6825 engagements
"Cogent Biosciences $COGT drug improves symptoms of chronic immune disorder study results show A comparison of the therapy to a rival treatment from Blueprint Medicines $BPMC remains muddled" @adamfeuerstein on X 2025-07-07 14:59:13 UTC 119.3K followers, 10.4K engagements
"Small biotech Abivax $ABVX scores major win with ulcerative colitis trials Stock trading +400% to $XX this morning. Incredible via @DrewQJoseph" @adamfeuerstein on X 2025-07-23 09:24:04 UTC 119.4K followers, 12.9K engagements
"George Tidmarsh named new CDER chief per Bloomberg" @adamfeuerstein on X 2025-07-21 10:42:10 UTC 119.4K followers, 12.5K engagements
"Just in the past week Takeda announced that two late-stage trials succeeded and Alkermes disclosed its mid-stage study was positive saying that its therapy helped patients reach normal levels of wakefulness. Along with Centessa Pharmaceuticals the drugmakers are also testing orexin candidates in narcolepsy type X and idiopathic hypersomnia other sleep conditions that the drugs have shown early potential to treat. In these three rare sleep disorders alone analysts project a greater than $X billion market with potential to grow even bigger as more patients seek diagnoses and treatment" @adamfeuerstein on X 2025-07-22 12:19:30 UTC 119.4K followers, 5107 engagements
"$SRPT Fully updated story w/ Brazil Japan suspensions Elevidys patient death in Brazil said to be due to influenza Europe moves to reject embattled Duchenne muscular dystrophy gene therapy via @DrewQJoseph" @adamfeuerstein on X 2025-07-25 12:57:06 UTC 119.4K followers, 9865 engagements
"Regenerons Yancopoulos is still bitter over Praluent sales. Can Novartis do better $REGN $NVS $MDCO #JPM20" @adamfeuerstein on X 2020-01-15 16:21:14 UTC 119.3K followers, XX engagements
"$SRPT Its always my fault. Or the medias fault. 🙄 Well folks I didnt cause Sareptas clinical trials to fail. I didnt decide to approve Elevidys for a broad swath of DMD patients. I dont treat patients nor influence whether they benefit or not. Im not responsible for liver failure hospitalizations or deaths. I didnt set Sareptas material disclosure policy. The FDA didnt ask for my advice on whether to ask Sarepta to halt shipments and Sarepta didnt consult with me when it refused. I dont work for Sarepta. I dont work for the FDA. I have no financial ties to Sarepta. No financial disclosures" @adamfeuerstein on X 2025-07-20 17:45:36 UTC 119.4K followers, 61.1K engagements
"$SRPT Bloomberg story just published confirmed our reporting from yesterday" @adamfeuerstein on X 2025-07-23 21:21:50 UTC 119.4K followers, 20.2K engagements
"$SRPT FDA Investigating Death of 8-Year-Old Boy Who Received Elevidys So sad" @adamfeuerstein on X 2025-07-25 21:39:41 UTC 119.4K followers, 33.8K engagements
"$SRPT just announced pause to all Elevidys shipments in the US" @adamfeuerstein on X 2025-07-21 23:45:13 UTC 119.4K followers, 46.7K engagements
"$SRPT CEO Doug Ingram concludes today's conference call by saying "We are a very transparent organization."" @adamfeuerstein on X 2025-07-18 15:16:53 UTC 119.3K followers, 25.8K engagements
"BREAKING: In surprise reversal Sarepta $SRPT says it will pause shipments of Duchenne gene therapy via @Jasonmmast and me" @adamfeuerstein on X 2025-07-22 00:26:59 UTC 119.4K followers, 24.6K engagements
"EXCLUSIVE: Sarepta Therapeutics $SRPT Duchenne therapy faces arduous path back to market senior FDA official says via @Jasonmmast and me" @adamfeuerstein on X 2025-07-22 18:35:13 UTC 119.4K followers, 49.1K engagements
"This week's Biotech Scorecard digs deeper into the Sarepta $SRPT #Duchenne gene therapy debacle. X. Sarepta may not survive. If Elevidys cannot return to the market (and STAT's reporting this week suggests it will not) the company is facing a severe cash flow and debt crisis. I dig deeper into the numbers. X. Putting business and stock prices aside this week has been wrenching for Duchenne families. On this week's Readout LOUD podcast we spoke with the mother of a boy who was treated with Elevidys. She wants Sarepta and the FDA to reach an agreement that returns Elevidys to the market. Listen" @adamfeuerstein on X 2025-07-24 12:35:14 UTC 119.4K followers, 24.8K engagements
"@Sanctuary_Bio @JacobPlieth @ApexOnco $COGT CEO leans too heavily into the $BPMC avi hate. Let the data speak for itself without the passive-aggressive insults. It's counterproductive" @adamfeuerstein on X 2025-07-07 18:55:24 UTC 119.3K followers, 2241 engagements
"$PFE bought a PD1xVEGF antibody from Chinas 3SBio. $1.25B upfront" @adamfeuerstein on X 2025-05-20 00:14:49 UTC 119.4K followers, 42.1K engagements
"$SRPT With Elevidys paused risk to balance sheet and solvency is an issue again. Obviously will depend on how long Elevidys remains off the market and whether Sarepta can restructure debt if necessary" @adamfeuerstein on X 2025-07-22 00:59:18 UTC 119.4K followers, 24K engagements
"More $SRPT news: FDA Requests Sarepta Therapeutics Suspend Distribution of Elevidys and Places Clinical Trials on Hold for Multiple Gene Therapy Products Following X Deaths Sarepta refused" @adamfeuerstein on X 2025-07-18 23:10:57 UTC 119.3K followers, 40.4K engagements
"What the f--k is this person talking about" @adamfeuerstein on X 2025-07-20 17:56:56 UTC 119.3K followers, 28.8K engagements
"Sanofi $SNY to buy vaccine biotech Vicebio for $1.15B upfront via @DrewQJoseph" @adamfeuerstein on X 2025-07-22 10:07:36 UTC 119.4K followers, 18.8K engagements
"Akeso and $SMMT Ivonescimab in Combination with Chemotherapy Demonstrates Statistically Significant and Strongly Positive Results in First-Line Treatment of Squamous Non-Small Cell Lung Cancer (sq-NSCLC) vs. Tislelizumab in Combination with Chemotherapy" @adamfeuerstein on X 2025-04-23 10:34:07 UTC 119.3K followers, 15.7K engagements
"Alkermes $ALKS drug helped narcolepsy patients stay awake in Phase X trial More orexin results but no numbers for now. via @elaineywchen" @adamfeuerstein on X 2025-07-21 10:09:56 UTC 119.3K followers, 9421 engagements
"Psychedelic therapy from $ATAI and Beckley Psytech shows promise in mid-stage study in treatment-resistant depression via @megkesh" @adamfeuerstein on X 2025-07-01 10:07:21 UTC 119.4K followers, 15.5K engagements
"Now official and then some. Sarepta Therapeutics $SRPT lays off one-third of workforce in drastic cost-cutting move w/ @Jasonmmast" @adamfeuerstein on X 2025-07-16 20:19:44 UTC 119.3K followers, 11K engagements
"CONFIRMED: FDA to request Sarepta Therapeutics $SRPT halt shipments of Duchenne gene therapy" @adamfeuerstein on X 2025-07-18 17:28:56 UTC 119.4K followers, 20.4K engagements
"Sarepta Therapeutics $SRPT the maker of a gene therapy for Duchenne muscular dystrophy that is being temporarily shelved because of safety concerns faces an arduous and treacherous path to try to get it back onto the market a senior official at the Food and Drug Administration told STAT suggesting the treatments license could be revoked" @adamfeuerstein on X 2025-07-22 18:35:55 UTC 119.4K followers, 16.8K engagements
"I'm just seeing this now but Joe Schwartz at Leerink is doing hero's work today on $SRPT" @adamfeuerstein on X 2025-07-19 00:33:33 UTC 119.4K followers, 35.7K engagements
"Needless to say the last XX hours have been stunning for $SRPT. Shocking. Frustrating. Aggravating. Maddening. The fallout will impact gene therapy and all of biotech" @adamfeuerstein on X 2025-07-18 17:38:32 UTC 119.3K followers, 78.4K engagements
"FDA rejecting $CAPR deramiocel follows STAT reporting last month. The ouster of the FDAs chief regulator of cell and gene therapies earlier this week came immediately after a disagreement with her boss over the review of a cell therapy for Duchenne muscular dystrophy STAT has learned. The regulator Nicole Verdun had scheduled an advisory committee meeting to review the therapy developed by Capricor Therapeutics. But Vinay Prasad director of the FDAs Center for Biologics Evaluation and Research was skeptical of the treatment and decided unilaterally to cancel the meeting according to a person" @adamfeuerstein on X 2025-07-11 10:47:22 UTC 119.3K followers, 42K engagements
"BioX in total might be dimmed these days but there are some individuals on this platform sharing fantastic and profitable investment ideas. BIG hat tip to @A_May_MD @Biohazard3737 @seedy19tron for an amazing call on $ABVX and anyone else who contributed to this. Wow" @adamfeuerstein on X 2025-07-23 09:27:57 UTC 119.4K followers, 8283 engagements
"The crisis over Sareptas $SRPT Duchenne therapy is a mess. But the lesson is clear via @matthewherper" @adamfeuerstein on X 2025-07-21 18:41:32 UTC 119.4K followers, 9946 engagements
"UnitedHealth $UNH confirms DOJ investigations into Medicare practices says its cooperating via @TaraBannow" @adamfeuerstein on X 2025-07-24 14:13:56 UTC 119.4K followers, 7178 engagements